Vikrant Vijay
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in ⓘ
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
- Co-authors
- Varsha G. Desai (16 shared papers)James C. Fuscoe (16 shared papers)Carrie L. Moland (14 shared papers)Qiang Shi (2 shared papers)Minjun Chen (1 shared paper)Hong Fang (1 shared paper)Zhichao Liu (1 shared paper)Weida Tong (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Biology of Sex Differences (3 papers)PLoS ONE (3 papers)Scientific Reports (1 paper)SAR and QSAR in environmental research (1 paper)
- Partner nations
- United StatesSouth KoreaIndia
In The Last Decade
Vikrant Vijay
28 papers receiving 827 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Pharmacology 209
- Cardiology and Cardiovascular Medicine 187
- Computational Theory and Mathematics 120
- Cancer Research 85
- Hepatology 43
Countries citing papers authored by Vikrant Vijay
This map shows the geographic impact of Vikrant Vijay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikrant Vijay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikrant Vijay more than expected).
Fields of papers citing papers by Vikrant Vijay
This network shows the impact of papers produced by Vikrant Vijay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikrant Vijay. The network helps show where Vikrant Vijay may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikrant Vijay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA-approved drug labeling for the study of drug-induced liver injury Hit paper breakdown → | 2011 | 296 |
| 2 | 2014 | 79 | |
| 3 | 2015 | 75 | |
| 4 | 2015 | 61 | |
| 5 | 2013 | 44 | |
| 6 | 2016 | 34 | |
| 7 | 2016 | 32 | |
| 8 | 2016 | 26 | |
| 9 | 2015 | 23 | |
| 10 | 2017 | 21 | |
| 11 | 2018 | 20 | |
| 12 | 2013 | 16 | |
| 13 | 2020 | 15 | |
| 14 | 2018 | 14 | |
| 15 | 2007 | 14 | |
| 16 | 2022 | 11 | |
| 17 | 2021 | 11 | |
| 18 | 2009 | 10 | |
| 19 | 2015 | 10 | |
| 20 | 2018 | 5 |
About Vikrant Vijay
Vikrant Vijay is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pharmaceutical Science, Materials Chemistry and Dermatology, having authored 29 papers that have together received 835 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Advancements in Transdermal Drug Delivery (4 papers), Carbon Nanotubes in Composites (4 papers), Cancer Treatment and Pharmacology (3 papers), Contact Dermatitis and Allergies (3 papers), Electron Spin Resonance Studies (3 papers), Analytical Chemistry and Chromatography (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Pharmacology (209 citations), Cardiology and Cardiovascular Medicine (187 citations), Computational Theory and Mathematics (120 citations), Cancer Research (85 citations) and Hepatology (43 citations). Vikrant Vijay has collaborated with scholars based in United States, South Korea and India. Frequent co-authors include Varsha G. Desai, James C. Fuscoe, Carrie L. Moland, Qiang Shi, Minjun Chen, Hong Fang, Zhichao Liu, Weida Tong, Joshua C. Kwekel and Tao Han. Their work appears in journals such as Toxicology and Applied Pharmacology, Biology of Sex Differences, PLoS ONE, Scientific Reports and SAR and QSAR in environmental research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.